Aaron Slan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aaron Slan has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Andrew F. Leuchter
5 shared publicationsHewa Artin
TMS Clinical and Research Service, Neuromodulation Division, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, USA
5 shared publicationsJuliana Corlier
5 shared publicationsRalph J. Koek
5 shared publicationsAdesewa E. Adelekun
4 shared publicationsDavid E. Krantz
4 shared publications
Latest Publications
- Open Access
- 14 February 2026
- Published by Elsevier in Transcranial Magnetic Stimulation
- Vol. 6
Trajectories of patient-rated baseline-severe depressive symptoms during repetitive transcranial magnetic stimulation (rTMS) for major depressive disorder
- 14 February 2026
- Published by Elsevier in Transcranial Magnetic Stimulation
- Vol. 6
Open AccessTrajectories of patient-rated baseline-severe depressive symptoms during repetitive transcranial magnetic stimulation (rTMS) for major depressive disorder
- Open Access
- 7 January 2026
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 51 (5) , 813-821
Differential neural responses to rhythmic and patterned TMS protocols: Insights from EEG spectral analysis
Repetitive Transcranial Magnetic Stimulation (rTMS) engages brain networks for the treatment of Major Depressive Disorder (MDD), using either rhythmic (e.g., 10 Hz) or patterned (e.g., intermittent Theta Burst, or iTBS) stimulation protocols. The distinct effects of these protocols on brain function are not well understood. Sixteen subjects with MDD underwent a TMS–electroencephalography (TMS–EEG) “interrogation” paradigm, in which a broad range of rhythmic and patterned stimulation frequencies were administered in a randomized order to the left dorsolateral prefrontal cortex (L-DLPFC). rTMS-induced changes in oscillatory activity and effective connectivity to the DLPFC were examined at each frequency. Linear mixed-effects models revealed widespread changes in power and connectivity, with magnitude and regional distribution of change dependent upon both protocol and frequency of stimulation. Increases in beta band power were most prominent with patterned stimulation, while rhythmic stimulation increased both alpha and beta power at stimulation frequencies greater than 7 Hz ( p < 0.05). Source localization showed that patterned and rhythmic stimulation elicited activation in distinct subregions of the cingulate. Rhythmic and patterned stimulation also had distinct effects on connectivity: notably, only rhythmic stimulation increased connectivity with regions near the stimulation site, while only patterned stimulation decreased connectivity to the left precuneus. Both protocols increased the effective connectivity to the orbitofrontal cortex in the theta and beta response bands ( p < 0.05). These results indicate that rhythmic and patterned rTMS engage distinct brain regions in a protocol- and frequency-dependent manner. Future studies should examine how these mechanistic differences may relate to clinical outcomes.
- 7 January 2026
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 51 (5) , 813-821
Open AccessDifferential neural responses to rhythmic and patterned TMS protocols: Insights from EEG spectral analysis
Repetitive Transcranial Magnetic Stimulation (rTMS) engages brain networks for the treatment of Major Depressive Disorder (MDD), using either rhythmic (e.g., 10 Hz) or patterned (e.g., intermittent Theta Burst, or iTBS) stimulation protocols. The distinct effects of these protocols on brain function are not well understood. Sixteen subjects with MDD underwent a TMS–electroencephalography (TMS–EEG) “interrogation” paradigm, in which a broad range of rhythmic and patterned stimulation frequencies were administered in a randomized order to the left dorsolateral prefrontal cortex (L-DLPFC). rTMS-induced changes in oscillatory activity and effective connectivity to the DLPFC were examined at each frequency. Linear mixed-effects models revealed widespread changes in power and connectivity, with magnitude and regional distribution of change dependent upon both protocol and frequency of stimulation. Increases in beta band power were most prominent with patterned stimulation, while rhythmic stimulation increased both alpha and beta power at stimulation frequencies greater than 7 Hz ( p < 0.05). Source localization showed that patterned and rhythmic stimulation elicited activation in distinct subregions of the cingulate. Rhythmic and patterned stimulation also had distinct effects on connectivity: notably, only rhythmic stimulation increased connectivity with regions near the stimulation site, while only patterned stimulation decreased connectivity to the left precuneus. Both protocols increased the effective connectivity to the orbitofrontal cortex in the theta and beta response bands ( p < 0.05). These results indicate that rhythmic and patterned rTMS engage distinct brain regions in a protocol- and frequency-dependent manner. Future studies should examine how these mechanistic differences may relate to clinical outcomes.
- Open Access
- 19 August 2025
- Published by Springer Nature in Research Square
Efficacy of 5x5 accelerated versus conventional repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression
Accelerated repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for Major Depressive Disorder (MDD), with an FDA-cleared protocol utilizing 10 sessions of prolonged intermittent Theta Burst Stimulation (piTBS) per day for five days. However, it remains unclear how many sessions and pulses are necessary to achieve benefit. We examined efficacy of five stimulation sessions per day for five days (“5x5”) of either piTBS or individualized, electroencephalogram-based “resonant frequency” (RF) stimulation. We compared MDD symptom improvement (PHQ-9) between two groups: 1) accelerated patients (N = 40) undergoing 5x5 treatment (patients received piTBS or RF rTMS) and 2) conventional patients (N = 135) receiving standard once daily rTMS. Both protocols ameliorated MDD symptoms and there were no statistically significant differences in depression symptom changes (p = .07) between the accelerated 5x5 protocol (mean PHQ-9: pre-rTMS = 17.68, post-rTMS = 10.98) and conventional once-daily treatment (mean PHQ-9: pre-rTMS = 17.83, post-rTMS = 8.97). There was no significant difference in improvement between the piTBS and RF 5x5 protocols (p = 0.9). A PHQ-9 median split of 5x5 patients revealed that the top half of patients showed robust depression improvement (69%) while the bottom half received no significant benefit (8%) by day 5. However, the bottom half showed significant improvement (36%) at two-to-four-week follow up (p = 0.001). These results suggest 5x5 accelerated rTMS treatment is as effective as once daily rTMS treatment and that the efficacy of accelerated treatment may not be accurately assessed until weeks after treatment completion.
- 19 August 2025
- Published by Springer Nature in Research Square
Open AccessEfficacy of 5x5 accelerated versus conventional repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression
Accelerated repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for Major Depressive Disorder (MDD), with an FDA-cleared protocol utilizing 10 sessions of prolonged intermittent Theta Burst Stimulation (piTBS) per day for five days. However, it remains unclear how many sessions and pulses are necessary to achieve benefit. We examined efficacy of five stimulation sessions per day for five days (“5x5”) of either piTBS or individualized, electroencephalogram-based “resonant frequency” (RF) stimulation. We compared MDD symptom improvement (PHQ-9) between two groups: 1) accelerated patients (N = 40) undergoing 5x5 treatment (patients received piTBS or RF rTMS) and 2) conventional patients (N = 135) receiving standard once daily rTMS. Both protocols ameliorated MDD symptoms and there were no statistically significant differences in depression symptom changes (p = .07) between the accelerated 5x5 protocol (mean PHQ-9: pre-rTMS = 17.68, post-rTMS = 10.98) and conventional once-daily treatment (mean PHQ-9: pre-rTMS = 17.83, post-rTMS = 8.97). There was no significant difference in improvement between the piTBS and RF 5x5 protocols (p = 0.9). A PHQ-9 median split of 5x5 patients revealed that the top half of patients showed robust depression improvement (69%) while the bottom half received no significant benefit (8%) by day 5. However, the bottom half showed significant improvement (36%) at two-to-four-week follow up (p = 0.001). These results suggest 5x5 accelerated rTMS treatment is as effective as once daily rTMS treatment and that the efficacy of accelerated treatment may not be accurately assessed until weeks after treatment completion.
- 21 September 2024
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 179, 295-299
Safety and efficacy of targeting the supplementary motor area with double-cone deep transcranial magnetic stimulation vs figure-eight coil in treatment of obsessive-compulsive disorder with comorbid major depressive disorder
- 21 September 2024
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 179, 295-299
Safety and efficacy of targeting the supplementary motor area with double-cone deep transcranial magnetic stimulation vs figure-eight coil in treatment of obsessive-compulsive disorder with comorbid major depressive disorder
- 14 November 2023
- Published by Elsevier in Psychiatry Research
- Vol. 330, 115608
A comparison of self- and observer-rated scales for detecting clinical improvement during repetitive transcranial stimulation (rTMS) treatment of depression
- 14 November 2023
- Published by Elsevier in Psychiatry Research
- Vol. 330, 115608
A comparison of self- and observer-rated scales for detecting clinical improvement during repetitive transcranial stimulation (rTMS) treatment of depression